Baker Avenue Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $325K | Sell |
619
-28
| -4% | -$14.7K | 0.01% | 364 |
|
|
2025
Q1 | $410K | Sell |
647
-3
| -0.5% | -$1.9K | 0.01% | 323 |
|
|
2024
Q4 | $463K | Sell |
650
-23
| -3% | -$16.4K | 0.01% | 296 |
|
|
2024
Q3 | $707K | Buy |
+673
| New | +$707K | 0.02% | 255 |
|
|
2023
Q4 | – | Sell |
-44
| Closed | -$36.2K | – | 1211 |
|
|
2023
Q3 | $36.2K | Buy |
44
+1
| +2% | +$823 | ﹤0.01% | 561 |
|
|
2023
Q2 | $30.9K | Sell |
43
-743
| -95% | -$534K | ﹤0.01% | 589 |
|
|
2023
Q1 | $646K | Buy |
786
+106
| +16% | +$87.1K | 0.03% | 229 |
|
|
2022
Q4 | $491K | Buy |
+680
| New | +$491K | 0.03% | 247 |
|